Dimension Therapeutics Inc (DMTX) Upgraded at Zacks Investment Research – Markets Daily

Posted: May 2, 2017 at 4:41 pm


High Point Observer
Dimension Therapeutics Inc (DMTX) Upgraded at Zacks Investment Research
Markets Daily
According to Zacks, Dimension Therapeutics, Inc. is a biotechnology company which focuses on developing novel, liver-directed gene therapy treatments for severe, rare genetic disorders. The company's pipeline of programs includes DTX101, a lead gene ...
Dimension Therapeutics (DMTX) Earning Favorable News Coverage, Report ShowsSports Perspectives

all 4 news articles »

See the original post:
Dimension Therapeutics Inc (DMTX) Upgraded at Zacks Investment Research - Markets Daily

Related Posts

Comments are closed.

Archives